Thrombophilia screening in the acute phase of deep venous thrombosis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 69, Issue 6, 2009, Pages 633-635

  Münster, Anna Marie Bloch ^a   Sidelmann, Johannes Jakobsen ^b   Gram, Jørgen ^a  

^a Hospital of South West Denmark ^*  (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; COMPLEMENT COMPONENT C4 BINDING PROTEIN; PROTEIN C; PROTEIN S;

BLOOD SAMPLING; DEEP VEIN THROMBOSIS; HUMAN; LETTER; PHLEBOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SENSITIVITY AND SPECIFICITY; THROMBOPHILIA;

ACUTE-PHASE REACTION; ANTICOAGULANTS; ANTITHROMBINS; FACTOR VIII; HUMANS; PATIENT ADMISSION; PROTEIN C; PROTEIN S; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 72949119158     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365510903072012     Document Type: Letter

References (22)

1. Goldacre MJ, Roberts S, Yeates D, Griffith M. Hospital admission and mortality rates for venous thromboembolism in Oxford region, UK, 1975-1998. Lancet. 2000;355:1968-1969
2. Mellemkjaer L, Sorensen HT, Dreyer L, Olsen J, Olsen JH. Admission for and mortality from primary venous thromboembolism in women of fertile age in Denmark, 1977-1995. BMJ. 1999;319:820-821
3. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692-699
4. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 1. Thromb Haemost. 1996;76:651-662
5. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 2. Thromb Haemost. 1996;76:824-834
6. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167-1173
7. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:204S-33S.
8. Tripodi A, Mannucci PM. Laboratory investigation of thrombophilia. Clin Chem. 2001;47:1597-1606
9. Tripodi A. Issues concerning the laboratory investigation of inherited thrombophilia. Mol Diagn. 2005;9:181-186
10. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:401S-28S.
11. Bauer KA. The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med. 2001;135:367-373
12. Cumming AM, Shiach CR. The investigation and management of inherited thrombophilia. Clin Lab Haematol. 1999;21:77-92.
13. Conard J. Antithrombin activity and antigen. In: Jespersen J, Bertina RM, Haverkate F, editors. Laboratory techniques in thrombosis. A manual. 2nd revised edition of ECAT assay procedures. Dordrecht/Boston/London: Kluwer Academic Publishers; 1999. p. 121-128
14. Kovacs MJ, Kovacs J, Anderson J, Rodger MA, Mackinnon K, Wells PS. Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism. Clin Lab Haematol. 2006;28:9-13.
15. Toulon P, Gandrille S, Vitoux JF, Fiessinger JN, Sultan Y, Aiach M. High total and free protein S in patients with acute deep vein thrombosis. Thromb Res. 1990;59:213-217
16. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345:152-155
17. O'Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost. 2000;83:10-13
18. Weltermann A, Eichinger S, Bialonczyk C, Minar E, Hirschl M, Quehenberger P, Schönauer V, Kyrle PA. The risk of recurrent venous thromboembolism among patients with high factor IX levels. J Thromb Haemost. 2003;1:28-32.
19. van Hylckama Vlieq A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood. 2000;95:3678-3682
20. O'Donnell J, Tuddenham EG, Manning R, Kemball-Cook G, Johnson D, Laffan M. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost. 1997;77:825-828
21. Reitsma PH, Branger J, Van Den Blink B, Weijer S, Van Der Poll T, Meijers JC. Procoagulant protein levels are differentially increased during human endotoxemia. J Thromb Haemost. 2003;1:1019-1023
22. D'Angelo A, Vigano-D'Angelo S, Esmon CT, Comp PC. Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest. 1988;81:1445-1454